论文部分内容阅读
目的分析及探索对支气管哮喘重度发作患者采用甲泼尼龙琥珀酸钠进行治疗的临床效果。方法 80例支气管哮喘重度发作患者,随机分成对照组与研究组,每组40例。两组患者入院确诊后均给予常规临床治疗,在此基础上,对照组患者加用地塞米松进行治疗,研究组患者加用甲泼尼龙琥珀酸钠进行治疗。用药3 d后对两组患者的治疗效果进行评估比较分析,并观察两组患者的临床症状、体征改善时间。结果研究组患者治疗总有效率为100.0%,高于对照组的80.0%,差异具有统计学意义(P<0.05);研究组患者的喘息消失时间与哮鸣音消失时间均短于对照组,差异具有统计学意义(P<0.05)。结论对支气管哮喘重度发作患者采用甲泼尼龙琥珀酸钠进行治疗,可有效促进患者临床症状、体征的缓解,值得进一步推广。
Objective To analyze and explore the clinical effect of methylprednisolone sodium succinate in patients with severe bronchial asthma attack. Methods Eighty patients with severe bronchial asthma were randomly divided into control group and study group, 40 cases in each group. Two groups of patients admitted to hospital after diagnosis were given routine clinical treatment, on this basis, the control group of patients plus dexamethasone for treatment, the study group plus methylprednisolone sodium succinate for treatment. Three days after treatment, the therapeutic effects of two groups of patients were evaluated and compared, and the clinical symptoms and signs of the two groups were observed. Results The total effective rate of study group was 100.0%, higher than 80.0% of the control group, the difference was statistically significant (P <0.05); the duration of wheezing disappeared and wheeze disappeared in study group were shorter than that of control group, The difference was statistically significant (P <0.05). Conclusions The treatment of methylprednisolone sodium succinate in patients with severe bronchial asthma could effectively promote the clinical symptoms and signs of patients and deserve further promotion.